Trace Neuroscience Nets $101M in Series A Funding for ALS, Dementia Therapy Development Biopharmaceutical company Trace Neuroscience announced it has raised $101 million in a…
Trace Neuroscience Nets $101M in Series A Funding for ALS, Dementia Therapy Development Biopharmaceutical company Trace Neuroscience announced it has raised $101 million in a…